Skip to Main Content

Paper Details

Should Cancer Patients Receive Apixaban to Prevent Venous Thromboembolism? An Analysis of the AVERT Trial: January 2020 Annals of Emergency Medicine Journal Club.
Ann Emerg Med
1
2020
Author NameAffiliation
William B StubblefieldVanderbilt University Medical Center
Daniel Mark CourtneyUT Southwestern Medical Center
Wesley H SelfVanderbilt University Medical Center
  • 1 - 3

Datasets

Release 1.2